DIGITAL HEALTH ADVISORY

Strategy, Investment & Transaction Intelligence — grounded in proprietary data.

We help leadership teams move from signal to defensible strategic, investment, and M&A decisions.

Digital Health Has Matured. Governance Matters.

AI Output Inflation

More AI output
More dashboards
More noise

Fragmented Signals

Fragmented data
Unstructured signals
Opaque competition

Capital & Board Pressure

Board pressure
Capital discipline
Transaction risk

The constraint is no longer access to companies. It
is structured intelligence and accountable decisions.

AI accelerates output. HealthTech Alpha ensures reliability.
Advisory ensures accountability.

Built on the HealthTech
Alpha System of Record

  • Proprietary ecosystem intelligence
  • Healthcare-specific taxonomy
  • Evidence & partnership tracking
  • Governed AI workflows

Advisory layered on public data
generates slides.

Advisory grounded in a system of record
generates defensible decisions.

From Data to Defensible Decision

Every engagement concludes with explicit implications and recommended
next steps.

Strategy, Investment & Transaction Intelligence

Ecosystem Strategy & Market Mapping

WHEN CLIENTS ENGAGE

Entering a new TA or geography, redefining innovation focus, identifying structural white spaces

  • Structured ecosystem map
  • Competitive cluster analysis
  • White space identification
  • Strategic positioning memo

DECISION ENABLED

Where to compete and allocate capital.

Competitive & Strategic Benchmarking

WHEN CLIENTS ENGAGE

Responding to competitor innovation moves, preparing board updates, assessing differentiation gaps

  • Competitor heatmaps
  • Investment & partnership pattern analysis
  • Thematic positioning matrix
  • Strategic implications

DECISION ENABLED

Defensive and offensive strategic positioning.

Portfolio Evaluation & Governance

WHEN CLIENTS ENGAGE

Reviewing digital health portfolio exposure, budget reprioritisation, post-M&A integration assessment

  • Portfolio scorecard
  • Gap and duplication analysis
  • Venture-by-venture strategic fit review
  • Expand / renew / divest recommendations

DECISION ENABLED

Capital reallocation and governance optimisation.

Strategic Partner & M&A Target Identification

WHEN CLIENTS ENGAGE

Defined BD, alliance, or acquisition mandate, pipeline acceleration, investment thesis validation

  • Longlist to scored shortlist
  • Strategic fit analysis
  • Revenue synergy hypothesis
  • Partnership history and ecosystem position
  • Engagement-ready briefing packs

DECISION ENABLED

Accelerated partner engagement or acquisition prioritisation.

Transaction & Investment Due Diligence

WHEN CLIENTS ENGAGE

Pre-investment validation, pre-acquisition screening, strategic alliance risk assessment

  • Market positioning validation
  • Competitive advantage assessment
  • Partnership landscape exposure
  • Risk matrix and executive summary

DECISION ENABLED

Proceed, renegotiate, or decline the transaction.

Strategic, Investment & M&A Intelligence

We support corporate development teams, CVC units, and investors with structured
market validation and ecosystem-based diligence.

TRADITIONAL TRANSACTION ADVISORS
  • Financial
  • Legal
  • Operational
GALEN GROWTH
  • Market positioning validation
  • Competitive durability assessment
  • Ecosystem exposure analysis
  • Innovation scalability review
This clarifies scope without overreach.

Executive-Ready Outputs

  • Ecosystem Maps
  • Competitor Heatmaps
  • Portfolio Governance Scorecards
  • M&A Prioritisation Matrices
  • Due Diligence Validation Briefs
  • Transaction Risk Heatmaps
  • Executive Decision Memos

We do not deliver raw data exports.
We deliver decision-ready artifacts.

When Structured Data
Requires Augmentation

Where necessary, we deploy tailored primary research to validate market
adoption, leadership signals, and partner perception. Positioned as precision
augmentation — not generic research.

Who Engages Us

Pharma Innovation & BD

Digital health scouting and partnership strategy

MedTech Strategy

Competitive benchmarking and market entry

Health Insurers

Ecosystem mapping and innovation monitoring

Health Systems

Technology assessment and vendor evaluation

Corporate Venture Arms

Portfolio evaluation and governance intelligence

Institutional Investors

Market validation and ecosystem-based diligence

Private Equity & Growth Equity

Investment thesis validation and market sizing

All require traceable, defensible intelligence.

Engagement Formats

Sprint

2-4 WEEKS

A focused strategic question with executive-ready outputs.

Program

QUARTERLY / MULTI-PHASE

Ongoing ecosystem monitoring, pipeline development, and governance cadence.

Platform + Advisory Overlay

CONTINUOUS

HealthTech Alpha subscription with advisory support at defined decision inflexion points.

Move From Insight to
Defensible Decision.

Schedule a discussion to define your strategic, investment, or M&A question.